293 related articles for article (PubMed ID: 27333122)
21. Effectiveness and safety of tissue plasminogen activator in the management of complicated parapneumonic effusions.
Weinstein M; Restrepo R; Chait PG; Connolly B; Temple M; Macarthur C
Pediatrics; 2004 Mar; 113(3 Pt 1):e182-5. PubMed ID: 14993574
[TBL] [Abstract][Full Text] [Related]
22. Recombinant tissue plasminogen activator in the treatment of pleural infections in adults.
Froudarakis ME; Kouliatsis G; Steiropoulos P; Anevlavis S; Pataka A; Popidou M; Mikroulis D; Pneumatikos I; Bouros D
Respir Med; 2008 Dec; 102(12):1694-700. PubMed ID: 18824340
[TBL] [Abstract][Full Text] [Related]
23. Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients.
Kanellakis NI; Wrightson JM; Hallifax R; Bedawi EO; Mercer R; Hassan M; Asciak R; Hedley E; Dobson M; Dong T; Psallidas I; Rahman NM
BMJ Open Respir Res; 2019; 6(1):e000440. PubMed ID: 31673364
[TBL] [Abstract][Full Text] [Related]
24. Modified regimen intrapleural alteplase with pulmozyme in pleural infection management: a tertiary teaching hospital experience.
Cheong XK; Ban AY; Ng BH; Nik Abeed NN; Nik Ismail NA; Nik Fuad NF; Syed Zakaria SZ; Ghan SL; Abdul Hamid MF
BMC Pulm Med; 2022 May; 22(1):199. PubMed ID: 35581627
[TBL] [Abstract][Full Text] [Related]
25. Intrapleural fibrinolytics combined with image-guided chest tube drainage for pleural infection.
Levinson GM; Pennington DW
Mayo Clin Proc; 2007 Apr; 82(4):407-13. PubMed ID: 17418067
[TBL] [Abstract][Full Text] [Related]
26. The first use of combination of Intrapleural Fibrinolytics (Alteplase & DNAse) for pleural infection in Malaysia.
Muhammad Redzwan SRA
Med J Malaysia; 2019 Apr; 74(2):176-178. PubMed ID: 31079131
[TBL] [Abstract][Full Text] [Related]
27. New strategies to manage complicated pleural effusions.
Safiyeh M; Huang D
Crit Care; 2012 May; 16(3):312. PubMed ID: 22621656
[TBL] [Abstract][Full Text] [Related]
28. Intrapleural agents for pleural infection: fibrinolytics and beyond.
Rahman NM
Curr Opin Pulm Med; 2012 Jul; 18(4):326-32. PubMed ID: 22487944
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of chest tube administration of tissue plasminogen activator to treat retained hemothorax.
Stiles PJ; Drake RM; Helmer SD; Bjordahl PM; Haan JM
Am J Surg; 2014 Jun; 207(6):960-3. PubMed ID: 24495319
[TBL] [Abstract][Full Text] [Related]
30. Intrapleural Fibrinolytic Therapy versus Early Medical Thoracoscopy for Treatment of Pleural Infection. Randomized Controlled Clinical Trial.
Kheir F; Thakore S; Mehta H; Jantz M; Parikh M; Chee A; Kaphle U; Sisnega C; Fernandez-Bussy S; Majid A
Ann Am Thorac Soc; 2020 Aug; 17(8):958-964. PubMed ID: 32421353
[No Abstract] [Full Text] [Related]
31. Management of Noncommunicating Multiloculated Pleural Space Infection With Fibrinolytic Augmented Multiple Chest Tube Drainage.
Biswas A; Jantz MA; Barnes MD; Mehta HJ
J Bronchology Interv Pulmonol; 2016 Apr; 23(2):e14-7. PubMed ID: 27058724
[No Abstract] [Full Text] [Related]
32. Tissue plasminogen activator with prolonged dwell time effectively evacuates pleural effusions.
Townsend A; Raju H; Serpa KA; Pruett R; Razi SS; Tarrazzi FA; Tami CM; Block MI
BMC Pulm Med; 2022 Dec; 22(1):464. PubMed ID: 36471325
[TBL] [Abstract][Full Text] [Related]
33. Tissue plasminogen activator potently stimulates pleural effusion via a monocyte chemotactic protein-1-dependent mechanism.
Lansley SM; Cheah HM; Varano Della Vergiliana JF; Chakera A; Lee YC
Am J Respir Cell Mol Biol; 2015 Jul; 53(1):105-12. PubMed ID: 25474480
[TBL] [Abstract][Full Text] [Related]
34. Intrapleural tissue plasminogen activator for complicated pleural effusions.
Skeete DA; Rutherford EJ; Schlidt SA; Abrams JE; Parker LA; Rich PB
J Trauma; 2004 Dec; 57(6):1178-83. PubMed ID: 15625447
[TBL] [Abstract][Full Text] [Related]
35. Intrapleural alteplase in a patient with complicated pleural effusion.
Walker CA; Shirk MB; Tschampel MM; Visconti JA
Ann Pharmacother; 2003 Mar; 37(3):376-9. PubMed ID: 12639166
[TBL] [Abstract][Full Text] [Related]
36. Choice of intrapleural fibrinolytic agents in the treatment of adult complicated parapneumonic effusion and empyema: Network meta-analysis.
Yokoyama Y; Kuno T; Takagi H; Burfeind W
Asian Cardiovasc Thorac Ann; 2023 Jun; 31(5):451-458. PubMed ID: 37287257
[TBL] [Abstract][Full Text] [Related]
37. Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial.
Livingston MH; Mahant S; Ratjen F; Connolly BL; Thorpe K; Mamdani M; Maclusky I; Laberge S; Giglia L; Walton JM; Yang CL; Roberts A; Shawyer AC; Brindle M; Parsons SJ; Stoian CA; Cohen E
Trials; 2017 Jun; 18(1):293. PubMed ID: 28646887
[TBL] [Abstract][Full Text] [Related]
38. Combined intrapleural alteplase and DNase therapy in complicated pleural infection arising from postsurgery oesophageal leak.
Ng BH; Nik Abeed NN; Ban AY; Abdul Hamid MF
BMJ Case Rep; 2023 Aug; 16(8):. PubMed ID: 37591627
[TBL] [Abstract][Full Text] [Related]
39. Intrapleural tissue plasminogen activator and deoxyribonuclease therapy for pleural infection.
Piccolo F; Popowicz N; Wong D; Lee YC
J Thorac Dis; 2015 Jun; 7(6):999-1008. PubMed ID: 26150913
[TBL] [Abstract][Full Text] [Related]
40. Intrapleural Fibrinolytic Therapy in Patients With Nondraining Indwelling Pleural Catheters.
Vial MR; Ost DE; Eapen GA; Jimenez CA; Morice RC; O'Connell O; Grosu HB
J Bronchology Interv Pulmonol; 2016 Apr; 23(2):98-105. PubMed ID: 27058711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
